Splenectomy and Surgical Cytoreduction for Ovarian Cancer

By Chen L.-m.   Leuchter R.S.   Lagasse L.D.   Karlan B.Y.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 362-368

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

By Burger R.A.   DiSaia P.J.   Roberts J.A.   O'Rourke M.   Gershenson D.M.   Homesley H.D.   Lichtman S.M.   Barnes W.   Moore D.H.   Monk B.J.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 148-153

Elsevier

Access to resources Recommend Favorite

Results of Reinduction Therapy with Paclitaxel and Carboplatin in Recurrent Epithelial Ovarian Cancer

By Gronlund B.   Hogdall C.   Hansen H.H.   Engelholm S.A.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 128-134

Elsevier

Access to resources Recommend Favorite

Clinical Outcome of Tertiary Surgical Cytoreduction in Patients with Recurrent Epithelial Ovarian Cancer

By Fotopoulou Christina  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 49-57

Springer Publishing Company

Access to resources Recommend Favorite

Increased paclitaxel resistance in recurrent epithelial ovarian cancer: analysis of metachronous tumors

By Matsuo Koji   Im Dwight   Rosenshein Neil  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 325-327

Springer Publishing Company

Access to resources Recommend Favorite